Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 343

1.

Sol-Gel Synthesis and Characterization of Gels with Compositions Relevant to Hydrated Glass Alteration Layers.

Reiser JT, Ryan JV, Wall NA.

ACS Omega. 2019 Sep 26;4(15):16257-16269. doi: 10.1021/acsomega.9b00491. eCollection 2019 Oct 8.

PMID:
31616803
2.

Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.

Nusshag C, Rupp C, Schmitt F, Krautkrämer E, Speer C, Kälble F, Tamulyte S, Bruckner T, Zeier M, Reiser J, Weigand MA, Uhle F, Merle U, Morath C, Brenner T.

Crit Care Med. 2019 Oct 4. doi: 10.1097/CCM.0000000000004042. [Epub ahead of print]

PMID:
31584458
3.

Evaluating Mental Load During Realistic Driving Simulations by Means of Round the Ear Electrodes.

Wascher E, Arnau S, Reiser JE, Rudinger G, Karthaus M, Rinkenauer G, Dreger F, Getzmann S.

Front Neurosci. 2019 Sep 4;13:940. doi: 10.3389/fnins.2019.00940. eCollection 2019.

4.

Recording mobile EEG in an outdoor environment reveals cognitive-motor interference dependent on movement complexity.

Reiser JE, Wascher E, Arnau S.

Sci Rep. 2019 Sep 11;9(1):13086. doi: 10.1038/s41598-019-49503-4.

5.

Contribution of Coiled-Coil Assembly to Ca2+/Calmodulin-Dependent Inactivation of TRPC6 Channel and its Impacts on FSGS-Associated Phenotypes.

Polat OK, Uno M, Maruyama T, Tran HN, Imamura K, Wong CF, Sakaguchi R, Ariyoshi M, Itsuki K, Ichikawa J, Morii T, Shirakawa M, Inoue R, Asanuma K, Reiser J, Tochio H, Mori Y, Mori MX.

J Am Soc Nephrol. 2019 Sep;30(9):1587-1603. doi: 10.1681/ASN.2018070756. Epub 2019 Jul 2.

PMID:
31266820
6.

Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease.

Hayek SS, Landsittel DP, Wei C, Zeier M, Yu ASL, Torres VE, Roth S, Pao CS, Reiser J.

J Am Soc Nephrol. 2019 Jul;30(7):1305-1313. doi: 10.1681/ASN.2018121227. Epub 2019 Jun 6.

PMID:
31171572
7.

Investigating the Durability of Iodine Waste Forms in Dilute Conditions.

Asmussen RM, Ryan JV, Matyas J, Crum JV, Reiser JT, Avalos N, McElroy EM, Lawter AR, Canfield NC.

Materials (Basel). 2019 Feb 26;12(5). pii: E686. doi: 10.3390/ma12050686.

8.

Nonimmune cell-derived ICOS ligand functions as a renoprotective αvβ3 integrin-selective antagonist.

Koh KH, Cao Y, Mangos S, Tardi NJ, Dande RR, Lee HW, Samelko B, Altintas MM, Schmitz VP, Lee H, Mukherjee K, Peev V, Cimbaluk DJ, Reiser J, Hahm E.

J Clin Invest. 2019 Apr 1;129(4):1713-1726. doi: 10.1172/JCI123386. Epub 2019 Mar 18.

9.

uPAR isoform 2 forms a dimer and induces severe kidney disease in mice.

Wei C, Li J, Adair BD, Zhu K, Cai J, Merchant M, Samelko B, Liao Z, Koh KH, Tardi NJ, Dande RR, Liu S, Ma J, Dibartolo S, Hägele S, Peev V, Hayek SS, Cimbaluk DJ, Tracy M, Klein J, Sever S, Shattil SJ, Arnaout MA, Reiser J.

J Clin Invest. 2019 Apr 2;129(5):1946-1959. doi: 10.1172/JCI124793. eCollection 2019 Apr 2.

10.

Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography.

Sommerer C, Zeier M, Morath C, Reiser J, Scharnagl H, Stojakovic T, Delgado GE, März W, Kleber ME.

Sci Rep. 2019 Jan 24;9(1):475. doi: 10.1038/s41598-018-36960-6.

11.

MeSsAGe risk score: tool for renal biopsy decision in steroid-dependent nephrotic syndrome.

Chan CY, Resontoc LP, Qader MA, Chan YH, Liu ID, Lau PY, Than M, Yeo WS, Loh AH, Tan PH, Wei C, Reiser J, Biswas SK, Ng KH, Yap HK.

Pediatr Res. 2019 Mar;85(4):477-483. doi: 10.1038/s41390-019-0277-z. Epub 2019 Jan 15.

PMID:
30659270
12.

Identification of Rabbit Oviductal Fluid Proteins Involved in Pre-Fertilization Processes by Quantitative Proteomics.

Yu H, Hackenbroch L, Meyer FRL, Reiser J, Razzazi-Fazeli E, Nöbauer K, Besenfelder U, Vogl C, Brem G, Mayrhofer C.

Proteomics. 2019 Mar;19(5):e1800319. doi: 10.1002/pmic.201800319. Epub 2019 Feb 13.

PMID:
30637940
13.

Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.

Alachkar N, Li J, Matar D, Vujjini V, Alasfar S, Tracy M, Reiser J, Wei C.

BMC Nephrol. 2018 Dec 17;19(1):361. doi: 10.1186/s12882-018-1177-x.

14.

More expression, less function: cleaved dynamin in glomerular kidney disease.

Altintas MM, Reiser J.

J Pathol. 2019 Apr;247(4):413-415. doi: 10.1002/path.5217. Epub 2019 Jan 25.

PMID:
30549263
15.

Podocytes: Way to Go.

Altintas MM, Reiser J.

Am J Pathol. 2019 Feb;189(2):226-228. doi: 10.1016/j.ajpath.2018.11.003. Epub 2018 Dec 11.

PMID:
30543788
16.

Motility of human renal cells is disturbed by infection with pathogenic hantaviruses.

Hägele S, Müller A, Nusshag C, Reiser J, Zeier M, Krautkrämer E.

BMC Infect Dis. 2018 Dec 12;18(1):645. doi: 10.1186/s12879-018-3583-x.

17.

Eomesodermin driven IL-10 production in effector CD8+ T cells promotes a memory phenotype.

Reiser J, Sadashivaiah K, Furusawa A, Banerjee A, Singh N.

Cell Immunol. 2019 Jan;335:93-102. doi: 10.1016/j.cellimm.2018.11.008. Epub 2018 Dec 1.

PMID:
30528350
18.

Virus- and cell type-specific effects in orthohantavirus infection.

Hägele S, Müller A, Nusshag C, Reiser J, Zeier M, Krautkrämer E.

Virus Res. 2019 Jan 15;260:102-113. doi: 10.1016/j.virusres.2018.11.015. Epub 2018 Nov 30.

PMID:
30508604
19.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) is predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression.

Hoenigl M, Moser C, Funderburg N, Bosch R, Kantor A, Zhang Y, Eugen-Olsen J, Finkelman M, Reiser J, Landay A, Moisi D, Lederman MM, Gianella S; ACTG NWCS 411 study team.

Clin Infect Dis. 2018 Nov 12. doi: 10.1093/cid/ciy966. [Epub ahead of print]

PMID:
30418519
20.

Fetal Renal Echogenicity Associated with Maternal Focal Segmental Glomerulosclerosis: The Effect of Transplacental Transmission of Permeability Factor suPAR.

Shuster S, Ankawi G, Licht C, Reiser J, Wang X, Wei C, Chitayat D, Hladunewich M.

J Clin Med. 2018 Oct 4;7(10). pii: E324. doi: 10.3390/jcm7100324.

21.

Kidney-derived c-kit+ progenitor/stem cells contribute to podocyte recovery in a model of acute proteinuria.

Rangel EB, Gomes SA, Kanashiro-Takeuchi R, Saltzman RG, Wei C, Ruiz P, Reiser J, Hare JM.

Sci Rep. 2018 Oct 3;8(1):14723. doi: 10.1038/s41598-018-33082-x.

22.

Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple Myeloma.

Derman BA, Reiser J, Basu S, Paner A.

Int J Nephrol. 2018 Sep 5;2018:4654717. doi: 10.1155/2018/4654717. eCollection 2018.

23.

A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis.

Gills J, Moret R, Zhang X, Nelson J, Maresh G, Hellmers L, Canter D, Hudson M, Halat S, Matrana M, Marino MP, Reiser J, Shuh M, Laborde E, Latsis M, Talwar S, Bardot S, Li L.

Oncotarget. 2018 Aug 24;9(66):32718-32729. doi: 10.18632/oncotarget.26024. eCollection 2018 Aug 24.

24.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients.

Torino C, Pizzini P, Cutrupi S, Postorino M, Tripepi G, Mallamaci F, Reiser J, Zoccali C; PROGREDIRE Working Group.

Kidney Int Rep. 2018 May 22;3(5):1100-1109. doi: 10.1016/j.ekir.2018.05.004. eCollection 2018 Sep.

25.

Age-Related Differences in Pro-active Driving Behavior Revealed by EEG Measures.

Getzmann S, Arnau S, Karthaus M, Reiser JE, Wascher E.

Front Hum Neurosci. 2018 Aug 7;12:321. doi: 10.3389/fnhum.2018.00321. eCollection 2018.

26.

Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease.

Lv L, Wang F, Wu L, Wang JW, Cui Z, Hayek SS, Wei C, Reiser J, He K, Zhang L, Chen M, Zhao MH.

Nephrol Dial Transplant. 2018 Aug 13. doi: 10.1093/ndt/gfy265. [Epub ahead of print]

PMID:
30124995
27.

Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging.

Chen D, Xie R, Shu B, Landay AL, Wei C, Reiser J, Spagnoli A, Torquati A, Forsyth CB, Keshavarzian A, Sumner DR.

Ann N Y Acad Sci. 2019 Apr;1442(1):48-60. doi: 10.1111/nyas.13945. Epub 2018 Aug 12. Review.

PMID:
30101565
28.

Stop TRPC5 in Kidney Disease: A Game Changer for Renal Allograft Protection?

Wang X, Reiser J.

Transplantation. 2018 Jul;102(7):1027-1029. doi: 10.1097/TP.0000000000002209. No abstract available.

PMID:
29952922
29.

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Chen TK, Hayek SS, Tracy M, Lipkowitz MS, Appel LJ, Levey AS, Inker LA, Reiser J, Grams ME.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1013-1021. doi: 10.2215/CJN.13631217. Epub 2018 Jun 14.

30.

ACTH Gel in Resistant Focal Segmental Glomerulosclerosis After Kidney Transplantation.

Alhamad T, Manllo Dieck J, Younus U, Matar D, Alasfar S, Vujjini V, Wall D, Kanawati B, Reiser J, Brennan DC, Alachkar N.

Transplantation. 2019 Jan;103(1):202-209. doi: 10.1097/TP.0000000000002320.

PMID:
29894413
31.

Efficiency and Specificity of Targeted Integration Mediated by the Adeno-Associated Virus Serotype 2 Rep 78 Protein.

Li P, Marino MP, Zou J, Argaw T, Morreale MT, Iaffaldano BJ, Reiser J.

Hum Gene Ther Methods. 2018 Jun;29(3):135-145. doi: 10.1089/hgtb.2018.052.

32.

Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.

Hayek SS, Divers J, Raad M, Xu J, Bowden DW, Tracy M, Reiser J, Freedman BI.

J Am Heart Assoc. 2018 May 1;7(9). pii: e008194. doi: 10.1161/JAHA.117.008194.

33.

Single-nephron proteomes connect morphology and function in proteinuric kidney disease.

Höhne M, Frese CK, Grahammer F, Dafinger C, Ciarimboli G, Butt L, Binz J, Hackl MJ, Rahmatollahi M, Kann M, Schneider S, Altintas MM, Schermer B, Reinheckel T, Göbel H, Reiser J, Huber TB, Kramann R, Seeger-Nukpezah T, Liebau MC, Beck BB, Benzing T, Beyer A, Rinschen MM.

Kidney Int. 2018 Jun;93(6):1308-1319. doi: 10.1016/j.kint.2017.12.012. Epub 2018 Mar 9.

PMID:
29530281
34.

Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy.

Furusawa A, Reiser J, Sadashivaiah K, Simpson H, Banerjee A.

J Immunother. 2018 Feb/Mar;41(2):53-63. doi: 10.1097/CJI.0000000000000206.

35.

New Insights into Diabetic Kidney Disease: The Potential Pathogenesis and Therapeutic Targets.

Liu WJ, Reiser J, Park TS, Liu Z, Ishibe S.

J Diabetes Res. 2017;2017:3945469. doi: 10.1155/2017/3945469. Epub 2017 Nov 8. No abstract available.

36.

Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation.

Alasfar S, Matar D, Montgomery RA, Desai N, Lonze B, Vujjini V, Estrella MM, Manllo Dieck J, Khneizer G, Sever S, Reiser J, Alachkar N.

Transplantation. 2018 Mar;102(3):e115-e120. doi: 10.1097/TP.0000000000002008.

37.

Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease.

Ren G, Tardi NJ, Matsuda F, Koh KH, Ruiz P, Wei C, Altintas MM, Ploegh H, Reiser J.

Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F471-F482. doi: 10.1152/ajprenal.00691.2016. Epub 2017 Nov 22.

38.

Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study.

Hayek SS, Ko YA, Awad M, Ahmed H, Gray B, Hosny KM, Aida H, Tracy MJ, Wei C, Sever S, Reiser J, Quyyumi AA.

Kidney Int Rep. 2017 Feb 9;2(3):425-432. doi: 10.1016/j.ekir.2017.02.001. eCollection 2017 May.

39.

TRPC5 Does Not Cause or Aggravate Glomerular Disease.

Wang X, Dande RR, Yu H, Samelko B, Miller RE, Altintas MM, Reiser J.

J Am Soc Nephrol. 2018 Feb;29(2):409-415. doi: 10.1681/ASN.2017060682. Epub 2017 Oct 23.

40.

High-content screening assay-based discovery of paullones as novel podocyte-protective agents.

Lee HW, Arif E, Altintas MM, Quick K, Maheshwari S, Plezia A, Mahmood A, Reiser J, Nihalani D, Gupta V.

Am J Physiol Renal Physiol. 2018 Feb 1;314(2):F280-F292. doi: 10.1152/ajprenal.00338.2017. Epub 2017 Oct 18.

41.

Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children.

Schaefer F, Trachtman H, Wühl E, Kirchner M, Hayek SS, Anarat A, Duzova A, Mir S, Paripovic D, Yilmaz A, Lugani F, Arbeiter K, Litwin M, Oh J, Matteucci MC, Gellermann J, Wygoda S, Jankauskiene A, Klaus G, Dusek J, Testa S, Zurowska A, Caldas Afonso A, Tracy M, Wei C, Sever S, Smoyer W, Reiser J; ESCAPE Trial Consortium and the 4C Study Group.

JAMA Pediatr. 2017 Nov 6;171(11):e172914. doi: 10.1001/jamapediatrics.2017.2914. Epub 2017 Nov 6. Erratum in: JAMA Pediatr. 2017 Nov 1;171(11):1127.

42.

Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.

Samman Tahhan A, Hayek SS, Sandesara P, Hajjari J, Hammadah M, O'Neal WT, Kelli HM, Alkhoder A, Ghasemzadeh N, Ko YA, Aida H, Gafeer MM, Abdelhadi N, Mohammed KH, Patel K, Arya S, Reiser J, Vaccarino V, Sperling L, Quyyumi A.

Atherosclerosis. 2017 Sep;264:108-114. doi: 10.1016/j.atherosclerosis.2017.06.019. Epub 2017 Jun 8.

43.

suPAR and chronic kidney disease-a podocyte story.

Zeier M, Reiser J.

Pflugers Arch. 2017 Aug;469(7-8):1017-1020. doi: 10.1007/s00424-017-2026-7. Epub 2017 Jul 8. Review.

PMID:
28689240
44.

Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function.

Madhusudhan T, Wang H, Ghosh S, Dong W, Kumar V, Al-Dabet MM, Manoharan J, Nazir S, Elwakiel A, Bock F, Kohli S, Marquardt A, Sögüt I, Shahzad K, Müller AJ, Esmon CT, Nawroth PP, Reiser J, Chavakis T, Ruf W, Isermann B.

Blood. 2017 Sep 21;130(12):1445-1455. doi: 10.1182/blood-2017-02-767921. Epub 2017 Jul 7.

45.

A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease.

Hayek SS, Koh KH, Grams ME, Wei C, Ko YA, Li J, Samelko B, Lee H, Dande RR, Lee HW, Hahm E, Peev V, Tracy M, Tardi NJ, Gupta V, Altintas MM, Garborcauskas G, Stojanovic N, Winkler CA, Lipkowitz MS, Tin A, Inker LA, Levey AS, Zeier M, Freedman BI, Kopp JB, Skorecki K, Coresh J, Quyyumi AA, Sever S, Reiser J.

Nat Med. 2017 Aug;23(8):945-953. doi: 10.1038/nm.4362. Epub 2017 Jun 26.

46.

Apoptosis and Compensatory Proliferation Signaling Are Coupled by CrkI-Containing Microvesicles.

Gupta KH, Goldufsky JW, Wood SJ, Tardi NJ, Moorthy GS, Gilbert DZ, Zayas JP, Hahm E, Altintas MM, Reiser J, Shafikhani SH.

Dev Cell. 2017 Jun 19;41(6):674-684.e5. doi: 10.1016/j.devcel.2017.05.014.

47.

Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.

Dande RR, Peev V, Altintas MM, Reiser J.

J Diabetes Res. 2017;2017:3232848. doi: 10.1155/2017/3232848. Epub 2017 May 17. Review.

48.

Extrarenal determinants of kidney filter function.

Hahm E, Peev V, Reiser J.

Cell Tissue Res. 2017 Jul;369(1):211-216. doi: 10.1007/s00441-017-2635-7. Epub 2017 May 30. Review.

49.

A High-Content Screening Technology for Quantitatively Studying Podocyte Dynamics.

Reiser J, Lee HW, Gupta V, Altintas MM.

Adv Chronic Kidney Dis. 2017 May;24(3):183-188. doi: 10.1053/j.ackd.2017.04.001. Review.

50.

Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.

Drechsler C, Hayek SS, Wei C, Sever S, Genser B, Krane V, Meinitzer A, März W, Wanner C, Reiser J.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1265-1273. doi: 10.2215/CJN.10881016. Epub 2017 May 11.

Supplemental Content

Loading ...
Support Center